Articles
Latest Articles
Analysis and perspective on direct-to-employer pharmacy programs, drug benefit integrity, and the structural changes reshaping pharmacy benefits.
Article
ERISA, CAA, and the Self-Funded Employer's Duty to Evaluate Direct Drug Channels
CAA 2026 raised the bar for pharmacy benefit fiduciary oversight. Self-funded employers now face personal liability for drug benefit decisions they cannot document. Here is what that means in practice.
Read MoreArticle
How Manufacturers Can Launch a Direct-to-Employer Drug Program
Launching a manufacturer direct-to-employer drug program requires more than pricing. Here is the operational infrastructure required to make a DTE channel work inside an employer benefit.
Read MoreArticle
What Is a Direct-to-Employer Pharmacy Benefit Program?
A direct-to-employer pharmacy benefit program lets self-funded employers access manufacturer-direct drug pricing inside their benefit, bypassing PBM intermediaries for targeted high-cost drugs.
Read More